Universe Pharmaceuticals INC (UPC)
USD 4.73
(-3.07%)
USD 4.73
(-3.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.52 Million USD | 49.76% |
| 2022 | -7.01 Million USD | -151.65% |
| 2021 | 13.59 Million USD | 32.56% |
| 2020 | 10.25 Million USD | 5.12% |
| 2019 | 9.75 Million USD | 1.0% |
| 2018 | 9.65 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.74 Million USD | 0.0% |
| 2023 Q4 | -3.67 Million USD | 0.0% |
| 2023 FY | -3.52 Million USD | 49.76% |
| 2023 Q2 | 149.25 Thousand USD | 0.0% |
| 2022 Q4 | -10.14 Million USD | 0.0% |
| 2022 FY | -7.01 Million USD | -151.65% |
| 2022 Q2 | 2.7 Million USD | 0.0% |
| 2021 FY | 13.59 Million USD | 32.56% |
| 2021 Q2 | 9.58 Million USD | 0.0% |
| 2021 Q4 | 4 Million USD | 0.0% |
| 2020 Q4 | 2.58 Million USD | 0.0% |
| 2020 FY | 10.25 Million USD | 5.12% |
| 2020 Q3 | 2.58 Million USD | 0.0% |
| 2020 Q2 | 2.58 Million USD | 0.0% |
| 2020 Q1 | 2.58 Million USD | 6.12% |
| 2019 Q2 | 2.43 Million USD | 0.0% |
| 2019 FY | 9.75 Million USD | 1.0% |
| 2019 Q4 | 2.43 Million USD | 0.0% |
| 2019 Q3 | 2.43 Million USD | 0.0% |
| 2018 Q3 | 2.41 Million USD | 0.0% |
| 2018 Q4 | 2.41 Million USD | 0.0% |
| 2018 Q2 | 2.41 Million USD | 0.0% |
| 2018 FY | 9.65 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -155.56 Million USD | 97.733% |
| Theratechnologies Inc. | -10.62 Million USD | 66.813% |
| Safety Shot Inc | -12.18 Million USD | 71.054% |
| Cosmos Health Inc. | -21.83 Million USD | 83.845% |
| Cronos Group Inc. | -81.37 Million USD | 95.666% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 101.687% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 90.992% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 128.158% |
| ProPhase Labs, Inc. | -21.61 Million USD | 83.682% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | 24.978% |
| Dynavax Technologies Corporation | -37.02 Million USD | 90.475% |
| Radius Health, Inc. | -3.92 Million USD | 10.146% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -40.217% |
| Alvotech | -354.86 Million USD | 99.006% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | 26.3% |
| Alpha Teknova, Inc. | -35.56 Million USD | 90.083% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 97.787% |
| SCYNEXIS, Inc. | 72.66 Million USD | 104.853% |
| Harrow Health, Inc. | 580 Thousand USD | 708.064% |
| Biofrontera Inc. | -22.67 Million USD | 84.448% |
| DURECT Corporation | -36.88 Million USD | 90.438% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | 33.066% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 107.508% |
| OptiNose, Inc. | -22.74 Million USD | 84.496% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 127.919% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 76.647% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | 43.216% |
| SIGA Technologies, Inc. | 83.62 Million USD | 104.218% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 137.796% |
| Shineco, Inc. | -17.06 Million USD | 79.334% |
| Phibro Animal Health Corporation | 53.31 Million USD | 106.615% |
| Procaps Group S.A. | 52.32 Million USD | 106.74% |
| TherapeuticsMD, Inc. | -8.52 Million USD | 58.621% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | 25.544% |
| Viatris Inc. | 766.2 Million USD | 100.46% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | 26.3% |
| Rockwell Medical, Inc. | -6.67 Million USD | 47.125% |
| Incannex Healthcare Limited | -30.04 Million USD | 88.26% |
| Aytu BioPharma, Inc. | -5.25 Million USD | 32.874% |
| Tilray Brands, Inc. | -174.74 Million USD | 97.982% |
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 102.112% |
| PetIQ, Inc. | 60.01 Million USD | 105.876% |
| Silver Spike Investment Corp. | 7.34 Million USD | 148.048% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 101.406% |
| Journey Medical Corporation | -2.07 Million USD | -70.129% |
| Alimera Sciences, Inc. | -1.47 Million USD | -139.754% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | 74.101% |
| Assertio Holdings, Inc. | -243.53 Million USD | 98.552% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | 40.147% |
| Embecta Corp. | 221.5 Million USD | 101.592% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 82.41% |
| Procaps Group, S.A. | 38.97 Million USD | 109.049% |
| PainReform Ltd. | -9.58 Million USD | 63.201% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 97.442% |
| Hempacco Co., Inc. | -8.81 Million USD | 59.979% |
| Talphera, Inc. | -16.88 Million USD | 79.118% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 104.023% |
| Alvotech | -354.86 Million USD | 99.006% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 100.967% |
| Kamada Ltd. | 10.06 Million USD | 135.043% |
| Indivior PLC | -4 Million USD | 11.831% |
| Currenc Group, Inc. | -6.64 Million USD | 46.932% |
| Evoke Pharma, Inc. | -7.43 Million USD | 52.539% |
| Flora Growth Corp. | -50.35 Million USD | 92.996% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 82.41% |
| Evolus, Inc. | -49.23 Million USD | 92.837% |
| HUTCHMED (China) Limited | 18.37 Million USD | 119.193% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 101.79% |
| Akanda Corp. | -10.05 Million USD | 64.913% |